MDT · MEDTRONIC PLC · Top AI ETF

Back to holdings

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products.

Close · 3M

+11.74%

Held by 1 AI ETF

AIVL3.356%

as of Sep 3

Signal performance

Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.

Buy signals20

Win rate90% (18/20)

Avg buy return+6.37%

AIVLnow 3.356% of fund23 signals

AIVL · Weight increase · 2d

weight 3.322% → 3.371% (+0.050 pp)·stock up 6.2% in the 30 days before

Aug 31·entry $90.65·now $93.10Drifting

+2.70%

since Aug 31

AIVL · Weight decrease · 2d

weight 3.452% → 3.368% (-0.084 pp)·stock up 8.2% in the 30 days before

Aug 25·entry $91.14·now $93.10

+2.15%

since Aug 25

AIVL · Accumulation · 5d

weight 3.308% → 3.433% (+0.126 pp)·stock up 11.6% in the 30 days before

Aug 24·entry $92.90·now $93.10Fresh

+0.22%

since Aug 24

AIVL · Accumulation · 5d

weight 3.339% → 3.452% (+0.113 pp)·stock up 13.8% in the 30 days before

Aug 21·entry $93.35·now $93.10Fresh

-0.27%

since Aug 21

AIVL · Accumulation · 5d

weight 3.291% → 3.461% (+0.170 pp)·stock up 14.3% in the 30 days before

Aug 19·entry $94.13·now $93.10Fresh

-1.09%

since Aug 19

AIVL · Accumulation · 5d

weight 3.202% → 3.391% (+0.189 pp)·stock up 10.6% in the 30 days before

Aug 18·entry $92.09·now $93.10Fresh

+1.10%

since Aug 18

AIVL · Accumulation · 5d

weight 3.176% → 3.329% (+0.153 pp)·stock up 8.9% in the 30 days before

Aug 17·entry $90.60·now $93.10Drifting

+2.76%

since Aug 17

AIVL · Weight decrease · 2d

weight 3.345% → 3.308% (-0.037 pp)·stock up 12.6% in the 30 days before

Aug 13·entry $90.58·now $93.10

+2.78%

since Aug 13

AIVL · Accumulation · 5d

weight 3.316% → 3.345% (+0.029 pp)·stock up 8.5% in the 30 days before

Aug 11·entry $90.68·now $93.10Drifting

+2.67%

since Aug 11

AIVL · Accumulation · 5d

weight 3.223% → 3.291% (+0.068 pp)·stock up 6.6% in the 30 days before

Aug 10·entry $89.41·now $93.10Drifting

+4.13%

since Aug 10

AIVL · Accumulation · 5d

weight 3.201% → 3.202% (+0.001 pp)·stock up 5.8% in the 30 days before

Aug 7·entry $87.16·now $93.10Drifting

+6.82%

since Aug 7

AIVL · Weight increase · 3d

weight 3.201% → 3.376% (+0.175 pp)·stock up 8.2% in the 30 days before

Jul 29·entry $87.54·now $93.10Drifting

+6.35%

since Jul 29

AIVL · Weight increase · 2d

weight 3.201% → 3.316% (+0.115 pp)·stock up 7.3% in the 30 days before

Jul 28·entry $86.88·now $93.10Drifting

+7.16%

since Jul 28

AIVL · Weight decrease · 2d

weight 3.250% → 3.201% (-0.048 pp)·stock up 3.3% in the 30 days before

Jul 22·entry $81.89·now $93.10

+13.69%

since Jul 22

AIVL · Accumulation · 5d

weight 3.228% → 3.250% (+0.022 pp)·stock up 6.6% in the 30 days before

Jul 20·entry $83.29·now $93.10Chased

+11.78%

since Jul 20

AIVL · Weight increase · 3d

stock up 2.3% in the 30 days before

Jul 17·entry $83.20·now $93.10Chased

+11.90%

since Jul 17

AIVL · Weight increase · 2d

stock up 4.0% in the 30 days before

Jul 16·entry $83.56·now $93.10Chased

+11.42%

since Jul 16

AIVL · Weight decrease · 2d

stock down 1.3% in the 30 days before

Jul 14·entry $79.30·now $93.10

+17.40%

since Jul 14

AIVL · Weight decrease · 2d

stock up 2.1% in the 30 days before

Jul 9·entry $82.39·now $93.10

+13.00%

since Jul 9

AIVL · Weight increase · 2d

stock up 12.8% in the 30 days before

Jul 2·entry $83.19·now $93.10Chased

+11.91%

since Jul 2

AIVL · Weight decrease · 2d

stock up 3.8% in the 30 days before

Jun 25·entry $80.52·now $93.10

+15.62%

since Jun 25

AIVL · Weight decrease · 2d

stock up 1.4% in the 30 days before

Jun 22·entry $79.27·now $93.10

+17.45%

since Jun 22

AIVL · Weight decrease · 4d

stock up 5.2% in the 30 days before

Jun 12·entry $80.20·now $93.10

+16.08%

since Jun 12

LQAIno longer held7 signals

LQAI · Exit · 1d

weight 0.380% → 0 (exited)·stock up 4.8% in the 30 days before

Aug 6·entry $85.92·now $93.10

+8.36%

since Aug 6

LQAI · Weight increase · 4d

weight 0.350% → 0.400% (+0.050 pp)·stock up 8.2% in the 30 days before

Jul 29·entry $87.54·now $93.10Drifting

+6.35%

since Jul 29

LQAI · Weight increase · 3d

weight 0.350% → 0.390% (+0.040 pp)·stock up 7.3% in the 30 days before

Jul 28·entry $86.88·now $93.10Drifting

+7.16%

since Jul 28

LQAI · Weight increase · 2d

weight 0.350% → 0.370% (+0.020 pp)·stock up 3.8% in the 30 days before

Jul 24·entry $83.21·now $93.10Chased

+11.89%

since Jul 24

LQAI · Weight decrease · 2d

weight 0.370% → 0.350% (-0.020 pp)·stock up 3.3% in the 30 days before

Jul 22·entry $81.89·now $93.10

+13.69%

since Jul 22

LQAI · Weight increase · 2d

stock up 4.0% in the 30 days before

Jul 16·entry $83.56·now $93.10Chased

+11.42%

since Jul 16

LQAI · New entry · 1d

stock up 2.3% in the 30 days before

Jul 7·entry $83.83·now $93.10Chased

+11.06%

since Jul 7

Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.

Buffett-style framework

Fails the frameworkas of Aug 23

AI ETF AIVL has been gradually accumulating Medtronic shares, suggesting its algorithms see a positive outlook or value proposition. This contrasts sharply with the Buffett-style framework's 'Fail' verdict, which identifies significant concerns regarding the company's financial health and the lack of a clear margin of safety at current prices.

Circle of CompetenceThe stable demand for essential medical devices and Medtronic's established market position within a regulated industry allow for reasonable long-term cash flow projections.
Economic MoatMedtronic benefits from a strong combination of high regulatory barriers, significant switching costs for healthcare providers, and a powerful brand reputation in critical medical devices.
ManagementThe provided financial data does not offer sufficient information to assess management's candor, capital allocation discipline, or skin in the game.
Financial HealthThe reported Return on Equity of 9.85% falls below the required threshold of 10%, indicating a failure in achieving superior returns on equity.
Margin of SafetyThe current valuation multiples, including a PER of 24.25 and EV/EBITDA of 26.25, do not indicate a clear discount to a conservative estimate of intrinsic value, especially given the insufficient ROE.

Medtronic PLC, while operating within a stable industry and possessing a strong economic moat, fails to meet the stringent financial health and margin of safety criteria of this value-investing framework. The primary concern is its reported Return on Equity falling below the required threshold, coupled with a valuation that does not offer a defensible discount. Therefore, despite its competitive advantages, it does not present itself as an attractive investment through this lens.

Educational interpretation generated by AI applying frameworks Warren Buffett documented in his shareholder letters and other public writings. Not a statement by Mr. Buffett or Berkshire Hathaway, and not investment advice.